metoclopramide hydrochloride Capsules, hard liquid 15 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Monaco
GMP approvals
EU GMP
Manufacturer #17667
This pharmaceutical company focuses on developing and manufacturing medications primarily for gastrointestinal disorders, oncology/hematology, and respiratory conditions. They offer a range of dosage forms including effervescent suppositories, powders, capsules, and inhalants. Key therapy areas include constipation, vomiting/nausea, chronic lymphocytic leukemia, and infectious diseases. While their primary production lines seem to be prescription medications, they may also produce over-the-counter drugs given their focus on gastrointestinal health. The company operates in regions like the EU and likely North America based on their website's design and language options.
None